Personalizing neurosurgical treatment through genetic discovery

Led by Dr. Chetan Bettegowda and Dr. Jordina Rincon-Torroella, our lab uses genetic analysis, biomarkers and patient outcome data to identify better ways to diagnose and treat disease. We research a variety of neurological conditions, including central nervous system tumors, trigeminal neuralgia and traumatic brain and spinal injuries.

Liquid Biopsy to Track Cancer

Dr. Bettegowda discusses one area of focus for his lab: a liquid biopsy for cancer. This blood test could help screen asymptomatic people to find cancers before they are detectable through other means and help doctors monitor treatment responses.

Learn more about the lab

To learn more about our work, discuss collaboration or connect about joining our team, contact Dr. Jordina Rincon-Torroella


Our lab is supported by several federal and private grants, including:

  • MRgFUS-enabled Non-Invasive Interrogation of Malignant Glioma via Circulating Tumor
    Source: DNA NINDS R21NS113016-01
  • Tumor Derived DNA in Cerebrospinal Fluid as a Biomarker for Central Nervous System Malignancies
    Source: NCI R37 CA230400-01
  • Translational Molecular Profiling of Oligodendrogliomas
    Source: Burroughs Wellcome Fund Career Award for Medical Scientists
  • Biomarkers for Children With Brain Tumors
    Source: Ian’s Friend’s Foundation
  • PTRON – Primary Tumor Research and Outcome Network
    Source: AOSpine

  • Alpha-1 Andrenergic Receptor Antagonism to Prevent COVID-19 Cytokine Storm Syndrome and Acute Respiratory Distress
    Source: Progressive Learning Inc.
  • Assessment of Safety and Feasibility of Exablate Type 2 Blood
    Source: INSIGHTEC
  • Quantitative Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme
    Source: NIH/University of Florida R01 FD007271-01
  • MTRON – Metastatic Tumor Research and Outcome Network
    Source: AOSpine